[
    {
        "title": "TSX Today: What to Watch for in Stocks on Tuesday, October 3 - msnNOW",
        "description": "TSX Today: What to Watch for in Stocks on Tuesday, October 3  msnNOW",
        "published date": "Tue, 03 Oct 2023 13:37:02 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiiwFodHRwczovL3d3dy5tc24uY29tL2VuLWNhL21vbmV5L3RvcHN0b3JpZXMvdHN4LXRvZGF5LXdoYXQtdG8td2F0Y2gtZm9yLWluLXN0b2Nrcy1vbi10dWVzZGF5LW9jdG9iZXItMy9hci1BQTFoRDdpQT9vY2lkPWZpbmFuY2UtdmVydGhwLWZlZWRz0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "MAIA Biotechnology Announces FDA Clearance of IND Application for THIO, a First-in-Class Telomere Targeting Agent for the Treatment of Non-Small Cell Lung Cancer - Yahoo Finance",
        "description": "MAIA Biotechnology Announces FDA Clearance of IND Application for THIO, a First-in-Class Telomere Targeting Agent for the Treatment of Non-Small Cell Lung Cancer  Yahoo Finance",
        "published date": "Tue, 03 Oct 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9tYWlhLWJpb3RlY2hub2xvZ3ktYW5ub3VuY2VzLWZkYS1jbGVhcmFuY2UtMTIwMTAwODE3Lmh0bWzSAWBodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9tYWlhLWJpb3RlY2hub2xvZ3ktYW5ub3VuY2VzLWZkYS1jbGVhcmFuY2UtMTIwMTAwODE3Lmh0bWw?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Atai, Cybin Give Positive Psychedelic Drug Study Updates - Green Market Report",
        "description": "Atai, Cybin Give Positive Psychedelic Drug Study Updates  Green Market Report",
        "published date": "Tue, 03 Oct 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWmh0dHBzOi8vd3d3LmdyZWVubWFya2V0cmVwb3J0LmNvbS9hdGFpLWN5YmluLWdpdmUtcG9zaXRpdmUtcHN5Y2hlZGVsaWMtZHJ1Zy1zdHVkeS11cGRhdGVzL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Compugen to Present at Single Cell Genomics 2023 Meeting - PR Newswire",
        "description": "Compugen to Present at Single Cell Genomics 2023 Meeting  PR Newswire",
        "published date": "Tue, 03 Oct 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicGh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvY29tcHVnZW4tdG8tcHJlc2VudC1hdC1zaW5nbGUtY2VsbC1nZW5vbWljcy0yMDIzLW1lZXRpbmctMzAxOTQ1NTIzLmh0bWzSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Predictive Policing Software Terrible At Predicting Crimes - Slashdot",
        "description": "Predictive Policing Software Terrible At Predicting Crimes  Slashdot",
        "published date": "Tue, 03 Oct 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiamh0dHBzOi8veXJvLnNsYXNoZG90Lm9yZy9zdG9yeS8yMy8xMC8wMy8yMDU0MjM4L3ByZWRpY3RpdmUtcG9saWNpbmctc29mdHdhcmUtdGVycmlibGUtYXQtcHJlZGljdGluZy1jcmltZXPSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Neffy A GameChanging Treatment for Allergies - Best Stocks",
        "description": "Neffy A GameChanging Treatment for Allergies  Best Stocks",
        "published date": "Tue, 03 Oct 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiRGh0dHBzOi8vYmVzdHN0b2Nrcy5jb20vbmVmZnktYS1nYW1lY2hhbmdpbmctdHJlYXRtZW50LWZvci1hbGxlcmdpZXMv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Administration Outlines Commercial and Residential Development ... - Medford, MA",
        "description": "Administration Outlines Commercial and Residential Development ...  Medford, MA",
        "published date": "Tue, 03 Oct 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMilgFodHRwczovL3d3dy5tZWRmb3JkbWEub3JnL2Fib3V0L25ld3MvZGV0YWlscy9-Ym9hcmQvY2l0eS1uZXdzL3Bvc3QvYWRtaW5pc3RyYXRpb24tb3V0bGluZXMtY29tbWVyY2lhbC1hbmQtcmVzaWRlbnRpYWwtZGV2ZWxvcG1lbnQtc3RyYXRlZ3ktZm9yLW1lZGZvcmTSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "6 Billionaires From CT Among Richest Americans: New Forbes List - Patch",
        "description": "6 Billionaires From CT Among Richest Americans: New Forbes List  Patch",
        "published date": "Tue, 03 Oct 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYWh0dHBzOi8vcGF0Y2guY29tL2Nvbm5lY3RpY3V0L2Fjcm9zcy1jdC82LWJpbGxpb25haXJlcy1jdC1hbW9uZy1yaWNoZXN0LWFtZXJpY2Fucy1uZXctZm9yYmVzLWxpc3TSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Purple Biotech Reports Positive Interim and Preliminary Results from NT219 Phase 1/2 Study in R/M Head & Neck Cancer - Yahoo Finance",
        "description": "Purple Biotech Reports Positive Interim and Preliminary Results from NT219 Phase 1/2 Study in R/M Head & Neck Cancer  Yahoo Finance",
        "published date": "Tue, 03 Oct 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9wdXJwbGUtYmlvdGVjaC1yZXBvcnRzLXBvc2l0aXZlLWludGVyaW0tMTE1MDAwOTk2Lmh0bWzSAV1odHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9wdXJwbGUtYmlvdGVjaC1yZXBvcnRzLXBvc2l0aXZlLWludGVyaW0tMTE1MDAwOTk2Lmh0bWw?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "The conjoined triplets of climate crisis conversation - People Daily",
        "description": "The conjoined triplets of climate crisis conversation  People Daily",
        "published date": "Wed, 04 Oct 2023 07:00:00 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiY2h0dHBzOi8vd3d3LnBkLmNvLmtlL2ZlYXR1cmVzL29waW5pb24vdGhlLWNvbmpvaW5lZC10cmlwbGV0cy1vZi1jbGltYXRlLWNyaXNpcy1jb252ZXJzYXRpb24tMjA0NDMxL9IBZ2h0dHBzOi8vd3d3LnBkLmNvLmtlL2ZlYXR1cmVzL29waW5pb24vdGhlLWNvbmpvaW5lZC10cmlwbGV0cy1vZi1jbGltYXRlLWNyaXNpcy1jb252ZXJzYXRpb24tMjA0NDMxLz9hbXA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    },
    {
        "title": "Neurofibromatosis Pipeline, NDA Approvals, Clinical Trials, and Emerging Drugs (2023) | Companies - NFlec - Benzinga",
        "description": "Neurofibromatosis Pipeline, NDA Approvals, Clinical Trials, and Emerging Drugs (2023) | Companies - NFlec  Benzinga",
        "published date": "Wed, 04 Oct 2023 03:49:28 GMT",
        "url": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMimQFodHRwczovL3d3dy5iZW56aW5nYS5jb20vcHJlc3NyZWxlYXNlcy8yMy8xMC8zNTA3NzgyNS9uZXVyb2ZpYnJvbWF0b3Npcy1waXBlbGluZS1uZGEtYXBwcm92YWxzLWNsaW5pY2FsLXRyaWFscy1hbmQtZW1lcmdpbmctZHJ1Z3MtMjAyMy1jb21wYW5pZXMtbmZsZWN0aW_SAS1odHRwczovL3d3dy5iZW56aW5nYS5jb20vYW1wL2NvbnRlbnQvMzUwNzc4MjU?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1"
    }
]